SEC Form 4 · accession 0001209191-18-032663
TREVENA INC · TRVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Demitrack
Officer — Sr VP & Chief Medical Officer
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429560
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.78 | May 21, 2018 | A | 200,000 | A | — | May 21, 2028 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable with respect to one-sixteenth of the total number of shares subject to the option on a quarterly basis (every three months) from the Transaction Date listed above, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. Inducement Plan) as of each such vesting date.